{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"3.780","floor":"2.950"},"ipodate":{"start":"2010-02-08 00:00:00","end":"2010-02-11 00:00:00"},"minimumcapital":"3818.14","subscribed":"7.36","marketcap":"33.69億","H_marketcap":"--","pe":"16.62","codesrate":"79.97","link":"https://www1.hkexnews.hk/listedco/listconews/sehk/2010/0208/ltn20100208006_c.htm","ipopricing":"3.000","resultdate":"2010-02-18 00:00:00","enddate":"2010-02-11 00:00:00","listeddate":"2010-02-19 00:00:00","issuenumber":"30000.00萬","issuenumberhK":"3000.00萬","issuenumberother":"27000.00萬","grayprice":"--","sponsors":"香港上海匯豐銀行有限公司","raisemoney":"67670.00萬","use":"1、約45%（約304.5百萬港元）用于二零一零年及二零一一年上半年的市場拓展；\n2、約30%（約203.0百萬港元）用作資本開支；\n3、約10%（約67.7百萬港元）用于收購可加強本集團的現有產品組合及可利用本集團的現有分銷網絡的具潛力產品；\n4、約5%（約33.8百萬港元）用于產品開發；\n5、約10%（約67.7百萬港元）用作額外營運資本及其他公司常規用途。","shares":1000,"leadagent":"香港上海匯豐銀行有限公司,建銀國際金融有限公司","bookrunners":"香港上海匯豐銀行有限公司","coordinator":"香港上海匯豐銀行有限公司","firstDayOpen":"2.99","IsEiio":0,"Interestdays":7,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"香港上海匯豐銀行有限公司","code":"E02010","name":"瑞年國際","fullname":"瑞年國際有限公司"},"institutioninfo":{"principaloffice":"香港灣仔軒尼詩道256號The Hennessy28樓","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"","secretary":"潘翼鵬","telephone":"(852) 2388 5595","substantialshareholders":"王福才(18.28%)","principalactivities":"生產及銷售營養保健品及藥品。","website":"http://www.ruinian.com.cn"},"managerinfo":[],"investorinfo":[],"TotalShareholdingPercentage":0},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":519}